secwatch.observer — SEC 8-K summary
======================================

Issuer:     Attovia Therapeutics, Inc. (ATTO)
CIK:        0002058707
Form:       8-K
Filed at:   2026-08-06T20:12:58+00:00
Accession:  0001193125-26-338037
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Attovia Therapeutics closes IPO, adopts amended charter and bylaws
------------------------------------------------------------------

- IPO closed on August 6, 2026; amended charter and bylaws became effective.
- Common stock trades on Nasdaq under ticker ATTO.
- Prospectus dated August 4, 2026 describes capital stock provisions.
- Company qualifies as an emerging growth company under SEC rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2058707/000119312526338037/0001193125-26-338037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2058707/000119312526338037/d155197d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-338037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer